(Q81381426)
Statements
The JAK2 V617F tyrosine kinase mutation in myelodysplastic syndromes (MDS) developing myelofibrosis indicates the myeloproliferative nature in a subset of MDS patients (English)
Ohyashiki K
Aota Y
Akahane D
Gotoh A
Miyazawa K
Kimura Y
1 December 2005